Answer
Bolt Projects’ private‑placement is being structured as a “quick‑close” financing. The company’s filing states that the transaction is expected to close within 30 calendar days of the signing of the definitive agreements, after which the net proceeds will be placed in the corporate account and used to fund the company’s short‑term R&D and working‑capital needs.
From a trading perspective, this near‑term cash inflow should be reflected in the price well before the 30‑day window closes—typically the market prices in the “pre‑close” as investors price‑in the certainty of the capital raise. Once the placement closes, the added liquidity will likely support the stock’s upside, especially if the company can accelerate its biomaterial pipeline milestones. Traders can therefore anticipate a short‑term catalyst around the 30‑day mark (i.e., late‑May 2025) and may consider positioning ahead of that date, while remaining mindful of any potential closing‑delay disclosures that could temporarily depress the share price.